Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.
Source: US Top News and Analysis
Related Posts
Eli Lilly secures long-awaited FDA approval for its obesity pill. Here’s what to know
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time…
Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers
Xpeng’s deal to make software, hardware and even vehicles with VW Group in China shows…
Kushner’s Shady Dealings Shed Light on a Culture of Corruption Within Trump’s Inner Circle
The global energy landscape is once again on the brink of chaos as reports emerge…